Edition:
United States

H Lundbeck A/S (LUN.CO)

LUN.CO on Copenhagen Stock Exchange

379.00DKK
5:57am EDT
Change (% chg)

kr.-3.30 (-0.86%)
Prev Close
kr.382.30
Open
kr.383.70
Day's High
kr.383.70
Day's Low
kr.375.20
Volume
99,226
Avg. Vol
349,774
52-wk High
kr.477.70
52-wk Low
kr.280.80

Select another date:

Wed, Aug 8 2018

UPDATE 1-Lundbeck drops as its adjusted profit outlook fails to impress

COPENHAGEN, Aug 8 Shares in Lundbeck dropped as much as 10 percent on Wednesday after the Danish drugmaker failed to impress the market with revisions to its full-year profit outlook.

Lundbeck Q2 beats forecast, lifts 2018 guidance

COPENHAGEN, Aug 8 Danish drugmaker Lundbeck on Wednesday posted better than expected second quarter earnings and adjusted its full-year forecast to the upper end of the earlier guidance range.

Lundbeck looks to boost drug range with new CEO

COPENHAGEN, July 2 Danish pharmaceutical company Lundbeck has picked Deborah Dunsire as its new chief executive after former CEO Kaare Schultz was poached by Teva last year.

UPDATE 1-Drugmaker Lundbeck to settle U.S. charity probe for $52.6 mln

BOSTON, June 6 Danish drugmaker Lundbeck said on Wednesday that it will pay $52.6 million to resolve a U.S. probe into its financial support of patient assistance charitable foundations.

Drugmaker Lundbeck to settle U.S. charity probe for $52.6 mln

BOSTON, June 6 Danish drugmaker Lundbeck said on Wednesday that it had reached a deal to pay $52.6 million to resolve a U.S. probe into its financial support of patient assistance charitable foundations.

BRIEF-H Lundbeck says FDA updates Trintellix label to include data showing improvement in processing speed

* REG-FDA UPDATES TRINTELLIX® (VORTIOXETINE) LABEL TO INCLUDE DATA SHOWING IMPROVEMENT IN PROCESSING SPEED, AN IMPORTANT ASPECT OF COGNITIVE FUNCTION IN ACUTE MAJOR DEPRESSIVE DISORDER (MDD)

Select another date: